BIO's website hacked?
Browsing around the Biotechnology Industry Organization site late last night, I was surprised to find that BIO’s press release section […]
General Biotechnology
General Biotechnology
Amgen's patents protect Epogen. Again.
Amgen’s got a record of savvy patenting to protect their blockbusters, and they’ve just done it again. A U.S. Federal
General Biotechnology
Drug approvals fall. Who's to blame?
The FDA approved 38 drugs through July this year, down 31 percent from 55 approvals for the same period last
General Biotechnology
Google's healthcare ambitions — the ultimate second opinion
I’ve been trying to elucidate Google’s rumored healthcare plans for quite some time now. Google’s plans are outlined in these
Google's healthcare ambitions — the ultimate second opinion Read Post »
General Biotechnology
Drug firms don't disclose enough
The editor-in-chief of the New England Journal of Medicine accused three of the largest drug companies of ‘making a mockery‘
General Biotechnology
Genentech's Lessons For Big Pharma
How does Genentech do it? The biotech company focuses on science — not marketing, acquisitions, or patents
General Biotechnology
Clones' beef, milk same as regular
There is no difference between meat and milk from cloned livestock and those foods obtained from conventionally bred cattle, according
General Biotechnology
Will California's Stem Cell Initiative Reap Royalties?
When the backers of California’s stem cell initiative were seeking voter support last year, they not only promised cures for
Will California's Stem Cell Initiative Reap Royalties? Read Post »
General Biotechnology
Genetically Modified IP Launched
Genetically Modified IP Launched A paper appearing in this week’s edition of Nature is antiseptically entitled: ‘Gene transfer to plants
General Biotechnology
From the laboratory to the investment fund
From the laboratory to the investment fund How two Chilean scientists turned a graduate thesis into a business that is